Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic

The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastier, P.-L., Aisenberg, N., Durand, F., Lestang, P., Abedipour, D., Gallet de Santerre, O., Couloigner, V., Bequignon, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211708/
https://www.ncbi.nlm.nih.gov/pubmed/32417164
http://dx.doi.org/10.1016/j.anorl.2020.05.001
Descripción
Sumario:The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments.

Ejemplares similares